Immunovant (IMVT) Enterprise Value (2019 - 2026)
Immunovant (IMVT) recorded Enterprise Value of $7.15 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 234.4% from $2.14 billion a year earlier and up 71.7% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Enterprise Value (2019 - 2026) Analysis & Trends
On a TTM basis, Immunovant's Enterprise Value came in at $4.73 billion as of Jun 30, 2026, up 720.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $4.16 billion, up 89.8% from FY2025.
- Annual Enterprise Value has a five-year compound annual growth rate of 28.9% (FY2021 to FY2026).
- Across earlier fiscal years, Enterprise Value came in at $2.19 billion in FY2025 (-46.1%), $4.07 billion in FY2024 (+147.3%), $1.64 billion in FY2023 and $148 million in FY2022 (-87.4%).
- The fiscal Q1 2027 figure is the highest quarterly Enterprise Value in data going back to fiscal Q1 2020.
- On a year-over-year basis, Enterprise Value has increased for three consecutive quarters, with growth averaging 21.3% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 310.3% in fiscal Q3 2023, against a decline of 95.9% in fiscal Q1 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $4.16 billion (Q4 2026), $4.17 billion (Q3 2026) and $2.29 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Immunovant | 5.85 Bn | 2.63 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.15 Bn |
| Mar 31, 2026 | 4.16 Bn |
| Dec 31, 2025 | 4.17 Bn |
| Sep 30, 2025 | 2.29 Bn |
| Jun 30, 2025 | 2.14 Bn |
| Mar 31, 2025 | 2.19 Bn |
| Dec 31, 2024 | 3.27 Bn |
| Sep 30, 2024 | 3.71 Bn |
| Jun 30, 2024 | 3.30 Bn |
| Mar 31, 2024 | 4.07 Bn |
| Dec 31, 2023 | 5.42 Bn |
| Sep 30, 2023 | 4.78 Bn |
| Jun 30, 2023 | 2.15 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 31, 2022 | 1.86 Bn |
| Sep 30, 2022 | 244.91 Mn |
| Jun 30, 2022 | 27.24 Mn |
| Mar 31, 2022 | 148.00 Mn |
| Dec 31, 2021 | 453.73 Mn |
| Sep 30, 2021 | 440.34 Mn |
API Access
Immunovant Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();